Evidence map›Paper›PMID 40962972›Full record

SynthesisLasers in medical science2025

The use of laser monotherapy in the treatment of keloids and hypertrophic scars: A look at the carbon dioxide laser. A systematic review and meta-analysis.

Christophe Abi Zeid Daou, Nohra Ghaoui, Lana Ghzayel, Krishna Patel

Abstract readSystematic ReviewMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. An Overview of the Mechanisms of Fractional COLasers in medical science · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christophe Abi Zeid DaouDepartment of Otolaryngology - Head and Neck Surgery, American University of Beirut Medical Center, Beirut, Lebanon. caa26@mail.aub.edu.
Nohra GhaouiDepartment of Dermatology, American University of Beirut Medical Center, Beirut, Lebanon.
Lana GhzayelDepartment of Otolaryngology - Head and Neck Surgery, American University of Beirut Medical Center, Beirut, Lebanon.
Krishna PatelDepartment of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina, Charleston, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To evaluate the effectiveness of fractional CO2 laser monotherapy in treating HS and keloids compared to other laser treatments. A systematic review and meta-analysis were conducted by searching Medline, PubMed, and Cochrane databases for studies comparing fractional CO2 laser therapy to other laser treatments for hypertrophic scars and keloids. Data were analyzed using IBM SPSS Statistics, assessing Vancouver Scar Scale scores, percent improvement in scar characteristics, and patient satisfaction. The search yielded 8,656 articles, with seven studies meeting the inclusion criteria. Analysis included 404 patients with 506 scars. The meta-analysis showed that CO2 laser treatment resulted in significantly better mean VSS scores and percent improvement compared to other lasers. However, there were no significant differences in color, pliability, height, or vascularity improvements and patient satisfaction rates. Fractional CO2 laser therapy is effective in improving the appearance of HS and keloids, with superior outcomes in VSS scores compared to other lasers. Further studies are needed to confirm these findings and to explore combination therapies.

Indexed as

Cicatrix, HypertrophicKeloidLasers, GasHumansPatient SatisfactionTreatment OutcomeCO2 laserHypertrophic scarsKeloidsPulsed dye laserVancouver scar scale

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.